Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer's disease: Synthesis, in vitro characterization and brain uptake analysis-Reference-Cited by-同舟云学术

Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer's disease: Synthesis, in vitro characterization and brain uptake analysis

Published:2023-09 Issue: Volume:86 Page:104555
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Jain Dhara^ORCID,Hasan Nazeer^ORCID,Zafar Sobiya,Thakur Jitesh,Haider Kashif^ORCID,Parvez Suhel,Ahmad Farhan Jalees^ORCID

Funder

Department of Science and Technology

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Comprehensive review on Alzheimer's disease: causes and treatment;Breijyeh;Molecules,2020

2. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer ’ s disease;Kumar;J. Ethnopharmacol.,2018

3. New drugs A review of rivastigmine: a reversible cholinesterase inhibitor;Williams;Clin. Therapeut.,2003

4. Rivastigmine in the treatment of patients with Alzheimer's disease;Müller;Neuropsychiatric Dis. Treat.,2007

5. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions;Neves;Curr. Med. Chem.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in encapsulation of resveratrol for enhanced delivery;Food Chemistry;2024-12

2. Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease;Neuropharmacology;2024-11

3. New opportunities for antioxidants in amelioration of neurodegenerative diseases;Mechanisms of Ageing and Development;2024-10

4. Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability;Advanced Science;2024-08-05

5. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29